← Back to Search

aerobic exercise intervention for Ovarian Cancer

N/A

Waitlist Available

Led By Alice Ryan, PhD

Research Sponsored by Baltimore VA Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosis with cancer, stage I-IV

History of treatment with oxaliplatin, docetaxel, or paclitaxel, either alone or in combination with other agents

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 13 weeks

Awards & highlights

Study Summary

This trial will investigate whether exercise can help relieve neuropathic pain caused by chemotherapy.

Who is the study for?

This trial is for cancer survivors aged 21-70 who finished chemotherapy between 6 months and a year ago, can walk on a treadmill, and have neuropathic pain from the treatment. They must not be regular exercisers or have other types of neuropathy.Check my eligibility

What is being tested?

The study looks at how aerobic exercise and resistive training might reduce nerve pain caused by chemotherapy. Participants will either join an exercise program or be in a control group to compare outcomes.See study design

What are the potential side effects?

While specific side effects are not listed for exercising, potential risks may include muscle soreness, fatigue, or injury related to physical activity.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My cancer is between stage I and IV.

Select...

I have been treated with oxaliplatin, docetaxel, or paclitaxel.

Select...

I experience mild to severe chemotherapy-induced nerve pain.

Select...

I can walk on a treadmill.

Select...

I am between 21 and 70 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 13 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~13 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 13 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Sensory pain

Secondary outcome measures

Nerve fiber density

Trial Design

3Treatment groups

Experimental Treatment

Group I: resistive trainingExperimental Treatment1 Intervention

Intervention is for 12 weeks 3 times weekly with training on site.

Group II: controlExperimental Treatment1 Intervention

This is an attention control group with regular contact by study staff.

Group III: aerobic exerciseExperimental Treatment1 Intervention

Aerobic exercise intervention is for 12 weeks 3 times weekly with training on site.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

resistive training

2006

Completed Phase 2

~40

0 / 5Eligibility criteria met

Find a Location

Who is running the clinical trial?

Baltimore VA Medical CenterLead Sponsor

32 Previous Clinical Trials

3,065 Total Patients Enrolled

Alice Ryan, PhDPrincipal InvestigatorUniversity of Maryland at Baltimore School of Medicine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research taking into account the elderly demographic?

"This research venture is only open to people aged 21-70. Concerning those below the age of 18, there are 169 studies available and for elderly individuals above 65 years old, 5586 trials exist."

Answered by AI

Can people still join this medical experiment?

"From the details on clinicaltrials.gov, it appears that this medical investigation is no longer recruiting volunteers. It was initially published in March 2018 and last modified July 2021; however, there are currently 5,727 other trials searching for participants."

Answered by AI